Camlin Fine Sciences Ltd Q3 FY2026 Concall Summary

Key Takeaways

• Flat quarter, tariff play underway: Revenue was flat QoQ at ₹572 crores as management deliberately held back ~200 tons of Vanillin sales to capture a \$2–\$3/kg tariff benefit in Q4 and Q1.
• Margin reset from straights and fire: EBITDA margin slipped 55 bps QoQ to 6.7%, squeezed by lower straights realizations, fixed-cost absorption on the unsold Vanillin, and a warehouse fire in Brazil that destroyed raw material.
• FY27 guided for a step-change: Management guided Vanillin volumes to double toward 4,000 tons, Blends to grow 20–25%, gross margin to 46–47%, and EBITDA margin to 12–14%, all anchored on tariff relief and channel restocking.
• Europe and China liquidation removes two cash burns: The Europe liquidation hearing is set for February 2026; China winding up is expected by end of this quarter. Together they bleed ~₹9 crores a quarter, a drag that stops once the processes conclude.
• What to watch next quarter: Whether the 600–700 tons of Q4 Vanillin sales materialize at the guided higher realization, the pace of insurance settlement for the Brazil fire, and any update on the US trade deal that could cut the tariff further to 18%.

The Vanillin Tariff Bet

• Deliberate volume deferral: Management held back ~200 tons of Vanillin sales in Q3, accepting a flat quarter to sell into Q4 and Q1 when a tariff reduction makes US realizations \$2–\$3/kg higher, a gain described as "plain cash and entire EBITDA."
• Q4 volume guided at 600–700 tons: Roughly 350–400 tons will go to the US at the improved price, with the rest sold in Europe at \$12–\$12.5/kg. The ethyl Vanillin campaign starting next week adds another ~300 tons of output.
• FY27 volume target of 4,000 tons: Management expects to roughly double from the current ~2,300–2,400 ton run-rate, citing channel inventory liquidation and market opening. Customers are still on quarterly contracts, not long-term commitments.
• US pricing is competitor-defined: The US market leader sets the price just below the anti-dumping duty impact level. Management expects only a ~\$1 increase as channel stocks decline, not a full match to the tariff differential.
• Tariff uncertainty lingers: The current 25% duty is expected to drop to 18% once a trade deal is signed, but management cautioned that the prior reduction from 50% to 25% took six months longer than anticipated.

Momaya: "Currently, this is the price that they've defined. And as the channel stocks do come down, they will probably increase it by a dollar or so. I don't think they will take it to match it to the anti-dumping duty impact. They'll keep it just below that."

Blends: Acquisition-Led Growth, Stable Margins

• Blends grew 13% QoQ, 11% YoY: The Vinpai acquisition, closed December 1st, contributed ~₹13 crores in its first month. Organic growth was supplemented by Vitafor product launches in the US and Mexico.
• Vinpai is near breakeven, scaling fast: Currently just below EBITDA breakeven, Vinpai is targeted to grow 40–50% from its ~€11 million topline as Camlin provides market access. Full-quarter operating cost impact will be ~₹3.5–4 crores monthly plus ~₹1.5–2 crores in labor.
• Vitafor already profitable: Running at 4–5% to 10–12% EBITDA, with a FY27 target of €17–18 million topline, up from €12–13 million.
• Blends gross margins are stable: Management pushed back on any suggestion of falling Blend margins, clarifying that only the straights business (TBHQ, BHA) saw margin decline this year.
• FY27 Blends target of ₹1,350+ crores: 20–25% growth over the FY26 base of ~₹1,000 crores, driven by both organic expansion and the full-year contribution from Vinpai.

Straights & Chemicals: The Margin Drag

• Volume and realization pressure: Diphenol, Aroma, and straight chemicals saw lower volumes and a ~\$1/kg drop in TBHQ and BHA sale prices while input costs held steady, directly compressing gross margin.
• Gross margin slipped to 45.8%: The 9-month average of 46% eroded this quarter, driven by the straights weakness and the new Blend acquisition still settling. Management guided a recovery to 46–47% in FY27.
• Diphenol plant to run steady: Enough contracted volumes for hydroquinone and catechol are signed for H2 of the coming year, with Vanillin remaining the big outlet. No step-change in utilization is planned.

Operational Disruptions: Brazil Fire & Entity Liquidations

• Brazil blending unit fire: A brand-new Unit II with new equipment caught fire during commissioning, destroying all warehouse stock. Manufacturing impact is limited by contract manufacturing tie-ups, but raw material loss will force ~1 month of higher-cost local spot buying, pressuring Brazil margins temporarily. Topline is not expected to be affected.
• Insurance process just starting: The fire department has not yet granted access to assess structural integrity. Management called any impact quantification "very difficult to predict right now" and "very early days to say."
• Europe liquidation hearing in February 2026: If the tribunal accepts the petition, the entity dissolves and the ~₹7–8 crores quarterly cash bleed stops immediately. No money realization from the liquidation is expected.
• China winding up by end of this quarter: Documentation is filed; the process should conclude before FY26 ends. Cash bleed of ~₹1 crore per quarter may continue for up to two more quarters.
• Discontinued operations treatment: Europe (₹8 crores impact) and China (₹1 crore) are shown below the line, not in operational EBITDA.

Momaya: "Very difficult to predict right now whether there will be any impact. And if so, what will be the impact? At this point of time, in fact, the access to the premises has not been allowed as yet by the fire department, because they want to check the integrity of the structure and they don't want any other mishaps to happen."

Cost Structure & Balance Sheet

• Employee costs rose on acquisitions and bonuses: Vinpai added one month of salary; statutory bonuses were paid in American and Latin American markets around Diwali and Christmas. Management expects employee cost to stabilize, with only a few incremental hires.
• Other expenses to stay range-bound: The Vinpai-related step-up will persist at a full-quarter run-rate, but no further increases are expected until revenue growth demands it.
• No new CAPEX or borrowing: Maintenance CAPEX of ₹40–50 crores annually is the plan. Long-term borrowings are being repaid at ~₹40–50 crores per year, with no new debt on the horizon.
• Old loan provision taken: A provision was made for a very old advance term loan; management does not believe an accounting provision is required but is trying to recover the amount.

Guidance & Commitments

Key Metrics